价格

human recombinant insulin

未知生产厂商

生成 AI 研报

专利

每项发明一条，涵盖美国、欧洲、PCT 与中国的同族专利。

Polynucleotide and polypeptide sequence and methods thereof
US 8575322 B2申请人: MANOJ MULAKKAPURATH NARAYANAN优先权: 2009
CN
US
7 件公开
HIGHLY PURIFIED RECOMBINANT HUMAN INSULIN (RHI) API AND METHODS OF PRODUCING THE SAME
EP 3856141 A1申请人: AMPHASTAR PHARMACEUTICALS INC优先权: 2018
CN
EP
US
WO
5 件公开
METHOD FOR QUANTIFYING INSULIN SECRETION CAPACITY IN HUMAN CELL
US 20260219259 A1申请人: JUNTENDO EDUCATIONAL FOUND优先权: 2023
CN
EP
US
WO
4 件公开
Process for Producing Exogenous Protein in the Milk of Transgenic Mammals and a Process For Purifying Proteins Therefrom
US 2009187999 A1申请人: STERRENBELD BIOTECHNOLOGIE NORTH AMERICA INC优先权: 2008
CN
US
4 件公开
Treating hyperinsulinemia by killing beta cells with cytotoxic gene
US 2005137157 A1申请人: CHARLES F BRUNICARDI M D优先权: 2000
US
4 件公开
Hepatocyte delivery vehicle for delivery of a combination of recombinant human regular insulin and recombinant human insulin isophane to a mammal
US 7858116 B2申请人: SDG INC优先权: 2006
US
4 件公开
Method for preparing insulin glargine crystal
US 9187520 B2申请人: WANG DAMEI优先权: 2011
CN
US
3 件公开
Non-recombinant human insulin-like growth factor binding protein concentrate
US 12167255 B2申请人: SIEMENS HEALTHCARE DIAGNOSTICS INC优先权: 2015
CN
US
3 件公开
Modified nucleotide sequence encoding glucagon-like peptide-1 (GLP-1), nucleic acid construct comprising same for production of glucagon-like peptide-1 (GLP-1), human cells comprising said construct and insulin-producing constructs, and methods of use thereof
US 7829664 B2申请人: BOEHRINGER INGELHEIM INT优先权: 2007
US
3 件公开
Stable formulations of a hyaluronan-degrading enzyme
- US 9993529 B2
  申请人: YANG TZUNG HORNG优先权: 2012
  US
  3 件公开
- CN 103974715 A
  申请人: HALOZYME INC优先权: 2012
  CN

药物

human recombinant insulin

专利

Stable formulations of a hyaluronan-degrading enzyme